Purpose Earlier studies have shown that positron emission tomography (PET) imaging with the radioligand [ 18 F]MPPF allows for measuring the binding potential of serotonin 5-hydroxytryptamine 1A (5-HT 1A ) receptors in different regions of animal and human brain, including that of 5-HT 1A autoreceptors in the raphe nuclei. In the present study, we sought to determine if such data could be obtained in rat, with a microPET (R4, Concorde Microsystems). Methods Scans from isoflurane-anaesthetised rats (n=18, including six test-retest) were co-registered with magnetic resonance imaging data, and binding potential, blood to plasma ratio and radiotracer efflux were estimated according to a simplified reference tissue model.
Introduction
The brain serotonin [5-hydroxytryptamine (5-HT)] system regulates a variety of functions and behaviours (reviewed in [1, 2] ) via a neuronal network pervading most regions of the neuraxis [3] [4] [5] [6] [7] [8] and operating through at least 14 5-HT receptor subtypes [9] . Particular attention has been paid to the characterisation of the structural, pharmacological and functional properties of the serotonin 1A receptors (5-HT 1A R; e.g. [10] ) owing to their implication in different neurological and psychiatric diseases [11] and their established role in the action of antidepressants/anxiolytics, such as the selective serotonin reuptake inhibitors (reviewed in [12] ). 5-HT 1A R act as autoreceptors on the soma and dendrites of 5-HT neurons themselves, in the raphe dorsalis nucleus (RN), for example, and as somatodendritic (so-called postsynaptic) heteroreceptors in territories of 5-HT projection, such as hippocampus and cerebral cortex. Because 5-HT !A autoreceptors negatively control the firing and release of 5-HT neurons (reviewed in [13] ), their desensitisation, together with increased sensitivity and signalling of 5-HT 1A heteroreceptors [14] [15] [16] [17] [18] , is generally viewed as accounting for the increases in 5-HT neurotransmission underlying the efficacy of antidepressant treatments. [19, 20] . Preliminary radiopharmacological experiments have indicated that the regional distribution of [ 18 
F]
MPPF in rat brain matches the density of 5-HT 1A R binding sites [21, 22] . [ 18 F]MPPF has been successfully used for PET studies in cat, monkey and human brain (reviewed in [23] ).
An initial microPET study with [
18 F]MPPF has already shown high binding of this radioligand in the hippocampus of anaesthetised rat [21] . [ 18 F]MPPF microPET imaging is of particular interest in this species, in view of the detailed knowledge of its 5-HT system and the increasing use of rodent models for investigating a variety of pathological conditions and their treatment, including mood disorders. Moreover, combined immuno-electron microscopic studies of 5-HT 1A R and β-microprobe measurement of the in vivo binding of [ [24, 25] . Moreover, under similar conditions, decreases in binding potential (BP) have been measured with PET in the dorsal raphe nucleus of cat and human [26, 27] . From a brain imaging perspective, PET scanners designed to image small animals offer the advantage of having better spatial resolution (<1.85 mm) than full-size PET scanners (4 mm) but lower sensitivity. In this context, it was deemed useful to assess the applicability of the [
18 F]MPPF microPET strategy for quantifying 5-HT 1A R binding in the brain of living rats and its reliability over time, notably in an anatomical region as small as the DRN.
Materials and methods

Animals
All procedures involving animals and their care were conducted in strict accordance with the Guidelines for Care of Laboratory Animals of the French Ministère de l'Agriculture et de la Forêt (87-848) and the European Economic Community (86-60, EEC) and the Guide to the Care and Use of Experimental Animals (Ed2) of the Canadian Council on Animal Care. The magnetic resonance imaging (MRI) protocol was approved by the Ethics Committee of the Centre Léon Bérard (Lyon, France) and the microPET imaging protocol by the McGill University Animal Care Committee (Montreal, QC, Canada).
MRI data were obtained from a single adult male, SpragueDawley rat (Élevage Dépré, Saint Doulchard, France) weighing 250 g. The microPET experiments were carried out in 13 adult male, Sprague-Dawley rats (Charles River, St-Constant, QC, Canada) weighing 250±25 g. These rats were housed individually at a constant temperature (20-22°C) and under a 12-h light/dark cycle, with free access to food and water.
Magnetic resonance imaging
The MRI study was carried out on a 7-T Bruker BioSpin system (Bruker Biospin, Ettlingen, Germany) using a surface coil of 23 mm in diameter. After anaesthesia by inhalation of isoflurane (5% for 2 min followed by 2%) in air (2 L/min), the rat was placed in a heated mat-cushioned body holder (37°C), with its head immobilised by a hard palate piece. The MRI acquisition (BIO 7T, Bruker BioSpin MRI GmbH, resolution) consisted of a 3D anatomical scan of 38-min duration. A 22.5×20×22.5-mm field of view (FOV) was used to obtain a 256×128 matrix divided in 45 slices, with a resolution of 88×156×500 μm.
MicroPET scans [ 18 F]MPPF was obtained by nucleophilic fluoration of a nitro precursor as previously described in detail [20] . The radiochemical yield was in the order of 20-25% at the end of synthesis, with a specific activity of 37-111 GBq/μmol.
MicroPET imaging of [ 18 F]MPPF was performed with a MicroPET R4 (Siemens Preclinical Solutions, Knoxville, TN, USA) scanner, which has a volumetric resolution better than 15.6 μl within 20 mm of the centre of the FOV [28] . The spatial resolution of this scanner at the centre of the FOV is 1.85 mm full-width at half-maximum (FWHM) in the axial direction and 1.66 mm FWHM in the transaxial and tangential directions.
After isoflurane anaesthesia as above, the rat was placed in the body holder with its head affixed to the incisor bar. The laser guidance system at the front of the gantry was used to centre the brain in the FOV. A 10-min transmission scan was acquired using a rotating 57 Co point source, followed by a bolus injection of 7.4-11.1 MBq of [ 18 F]MPPF in the tail vein. Radioactivity was then measured in 27 sequential time frames of increasing duration (8×30, 6×60, 5×120 and 8×300 s) for a total duration of 60 min.
Sinograms were normalised, corrected for randoms, scatter, attenuation, dead time and radio element decay and finally reconstructed with a filtered backprojection (Hanning filter of cut-off 0.5 cycles/pixels). This allowed the dynamic study of 18 volumes, each with a 128×128 matrix divided in 63 slices and 0.6 mm 3 in voxel size.
Analysis of microPET data
Dynamic PET volumes from 0 to 60 min were integrated and manually co-registered with MRI data (Register-1.3.6 and Minc-2.0.9, MNI-BIC Software, Montreal, Canada) using a rigid body transformation with 6 degrees of freedom. The obtained transformation matrix was then applied to the dynamic PET volumes. A 20-mm 3 ellipse was drawn in the centre of the caudal area of cerebellum on the co-registered MRI (Display-1.3, MNI-BIC Software).
This allowed us to estimate the binding parameters of the tracer according to the simplified reference tissue model (SRTM), as previously applied to [ 11 C]WAY100635 [29] and to [ 18 F]MPPF in humans [30, 31] and very recently to [ 18 F]MPPF in rats [32] . The SRTM is based on the analytic solution of the compartment model for estimating three parameters without the use of an arterial sampling input function. In this model, BP is the ratio of available receptor density to receptor affinity, with BP % B' max =K' d (B' max being the apparent B max and K' d the apparent dissociation constant), k 2 is the tracer's efflux between the vascular system and R 1 is the ratio of plasma to brain transport constant in the volume of interest (VOI) and reference region (K 1 =K' 1 ). The cerebellum was used as the region of reference since it contains very few 5-HT 1A R in adult rat [33, 34] .
Parametric images of BP, k 2 and R 1 were calculated from individual voxel time-activity curves using Receptor Parametric Mapping software [35] . BP volumes were automatically co-registered using PET-to-PET cross-correlation with 7 degrees of freedom (mni_autoreg-0.99.3, MNI-BIC Software). The same transformation matrices were applied to parametric images of k 2 and R 1 . All 18 PET volumes of BP were averaged into a single volume, which was then fused with the MRI to draw the regions containing BP and regrouped into anatomical VOIs (Display-1.3, MNI-BIC Software). The Paxinos and Watson's stereotaxic atlas of the rat brain [36] (2 mm 3 ). Regional radioactivity concentration (kilobecquerel per cubic centimetre) was also measured in the dynamic PET volumes for each VOI and plotted versus time.
Test-retest variability (Eq. 1), intraclass correlation coefficient (Eq. 2) and the coefficient of variation (Eq. 3) were computed with the following equations:
MSBS and MSWS are the mean sum of squares between and within subjects, respectively; n is the number of withinsubject measurements, μ is the mean value and σ is the standard deviation. ICC represents the ratio of betweensubject variance to total variance and is the appropriate metric for assessing within-subject reliability. Therefore, ICC values will be particularly high when within-subject (i.e. within-subject between-session) variance is low and between-subject variance is high. CV is a measure of dispersion and often referred to as the relative standard deviation.
Regional BP values were checked for normality using d'Agostino and Pearson's omnibus normality test and then compared by one-way ANOVA with Bonferroni's post test.
Student's two-tailed paired t test was also used to assess regional differences in BP between test and retest scans (GraphPad Prism version 5, GraphPad Software, San Diego, CA, USA). 
Results
As previously observed in PET studies in cat [26, 37] and human (reviewed in [23] ), the regional radioactivity time curves after i.v. injection in the rat indicated an initial surge of [ 18 F]MPPF throughout brain, followed within minutes by a relatively rapid washout over the next hour, but at varying rates according to the region examined (Fig. 1) . At all time points, the highest radioactivity was that measured in the hippocampus, followed by septum, medial prefrontal cortex and raphe nuclei. The radioactivity in cerebellum dropped sharply in the first 5 min after the bolus injection of [
18 F]MPPF and remained low at all time points thereafter (Fig. 1) .
Receptor parametric mapping revealed the presence of specific 5-HT 1A BP in the medial prefrontal cortex, septum, amygdala, hippocampus, entorhinal cortex, raphe nuclei, paraventricular hypothalamic nucleus and raphe obscurus (Figs. 2 and 3) . The co-registration of BP and MRI images confirmed the raphe nuclei as the origin of [ 18 F]MPPF binding in mesencephalon, which was clearly discernible and easily delineated from its immediate surround in the coronal (Fig. 2) as well as sagittal and horizontal planes (Fig. 3) .
As measured with the SRTM (Table 1) , the highest BP value was that in hippocampus (1.10±0.20), followed by entorhinal (1.09±0.28), septum (1.08±0.19), medial prefrontal cortex (1.00±0.16), amygdala (0.84±0.11), DRN (0.58±0.11), paraventricular hypothalamic nucleus (0.53± 0.14) and raphe obscurus (0.52±0.16). The comparison of regional BP values indicated that most of the regions examined were significantly different from one another as shown in Fig. 4 .
The estimated regional values of k 2 ranged from 0.010± 0.005 in the raphe obscurus to 0.015±0.002 in the medial prefrontal cortex (Table 1 ). Regional differences in k 2 were only found in the medial prefrontal cortex, which differed significantly from the entorhinal cortex (p<0.05) and raphe obscurus (p<0.01; Fig. 4) .
Regional R 1 values ranged from 0.70±0.13 in the amygdala to 0.96±0.22 in the DRN (Table 1) . They differed significantly in DRN not only from those measured in the septum (p<0.05) and amygdala (p<0.001) but also between the latter region and raphe obscurus (p<0.01; Fig. 2 ).
As shown in Table 2 , the average percent changes between test and retest BP values ranged from 0.3% in the basolateral amygdaloid nucleus to 10.2% in the DRN, while BP test-retest variability ranged from 7% in hippocampus to 34% in the raphe obscurus. ICC values ranged from to −0.06 in the amygdala to 0.92 in the entorhinal cortex. The test-retest variability in DRN (18%) was comparable to that in the paraventricular hypothalamic nucleus (17%). There were no statistically significant differences between test and retest BP values when compared by Student's paired t test in the VOIs (Table 2) or by voxelwise analysis with SPM (data not shown).
Pretreatment with the 5-HT 1A agonist 8-OH-DPAT completely blocked the binding of [ 18 F]MPPF in all cerebral regions (data not shown).
Discussion
The radioactivity curves here obtained from five regions of rat brain, in the hour following the bolus injection of [ 18 F] MPPF, were comparable to those previously measured with PET in rats [21] , cats [20, 26, 37, 38] , non-human primates [21, 39] and humans [30, [40] [41] [42] . The hippocampus displayed the highest radioactivity, followed by septum, medial prefrontal cortex and raphe nuclei. A similar distribution pattern has also been reported using in vitro [19, 33, 43, 44] or ex vivo [45, 46] The present report provides regional estimates of [ 18 F] MPPF BP, k 2 and R 1 values for rat brain. As shown in Table 3 , the BP values were in the same range as those previously reported in various species using PET. Very recently, Millet et al. [32] have reported strikingly similar [ 18 F]MPPF BP values in the hippocampus and raphe nuclei of rats using the YAP-(S)PET scanner, even though their data were not corrected for attenuation or scatter.
The realignment procedure used in the determination of PET volumes, as described in the "Materials and methods", was crucial in obtaining reliable measurements from the various regions examined (see [47] ). In this way, a single template could be used to extract BP, k 2 and R 1 values from each volume, thus reducing the risk of a sampling bias associated with the drawing of ROIs. This method allowed us to estimate BP in regions that are not commonly sampled in microPET studies, such as the septum, PVN, amygdala, DRN and even smaller regions such as the raphe obscurus (Robs).
Despite our best efforts, however, a number of methodological constraints could not be avoided. Foremost, in view of the limited resolution of the microPET camera and the size of the smaller regions examined (raphe nuclei, PVN, RObs), it was likely that the BP values in these regions were underestimated due to partial volume effects, as previously noted with [ 11 C] WAY-100635 in human NRD [29, 48] . This underestimation might have been less with [
18 F]MPPF than [ 11 C] WAY-100635 because of the lower energy of the 18 F radionuclide, yet significant. On the other hand, a potential source of overestimation was the accumulation of radioactivity in the Harderian glands, located behind the eyes (visible in Figs. 2 and 3 ), which could have increased readings from adjacent regions such as the medial prefrontal cortex. It should also be noted that anaesthetics may affect the binding of radioligands to 5-HT 1A R by modulating the affinity state of G-protein-coupled receptors [49] , as convincingly shown to be the case for dopamine receptors [50, 51] .
Nevertheless, the reproducibility and reliability of our sampling method was evidenced by a relatively low variability in repeated measurements of BP and high ICC, at least in the larger brain regions examined (see Table 2 ). The regional values of test-retest variability were generally lower than those reported with [ 11 C]WAY-100635 in humans (e.g. hippocampus 26±21%, [48] ), but on par with those found with [ 18 F]MPPF in cats (e.g. hippocampus 7±6%, [26] ) and humans (e.g. hippocampus 7±3%, [31] ; e.g. hippocampus 11±11%, [27] [54, 55] and also to better characterise the activation and internalisation of 5-HT 1A autoreceptors by agonists [25, 56] , SSRIs [24, 26, 27, 57] and atypical antipsychotics [58] . Fig. 4 Regional values of BP, R 1 and k 2 . Data from 18 micro-PET scans, as described in the "Materials and methods". Regions showing statistically significant differences are linked by hooks with asterisks in front of the differing region(s). *p< 0.05, **p<0.01 and ***p< 0.001 by one-way ANOVA with Bonferroni's post test. MPFC Medial prefrontal cortex, Spt septum, Hip hippocampus, RN raphe nuclei, Ent entorhinal cortex, Am amygdala, PVN paraventricular hypothalamic nucleus, ROb raphe obscurus Means±SD from six rats (two scans per rat) 
